SCHEMBL22978732

SCHEMBL22978732

COc1ncccc1OC(=O)N1CCCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
KDM4E B2RXH2 2/20 0.55
MAPT P10636 2/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
HSD17B10 Q99714 1/20 0.55
SMN1; SMN2 Q16637 4/20 0.54
GAA P10253 1/20 0.54
TSHR P16473 2/20 0.49
NPSR1 Q6W5P4 2/20 0.48
RXFP1 Q9HBX9 1/20 0.48
POLB P06746 1/20 0.47
HPGD P15428 3/20 0.46
LMNA P02545 2/20 0.46
GLA P06280 1/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 2/20 0.46
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31246118 0.86 HTR1A (0.43) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL23851238 0.86 HTR1A (0.43) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL29078290 0.80 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL16835454 0.79 SMN1; SMN2 (0.63) ALDH1A1MEN1KMT2ASMN1; SMN2GAA
SCHEMBL28547792 0.78 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL26111081 0.75 ALDH1A1 (0.59) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL18297996 0.75 SMN1; SMN2 (0.76) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6523680 0.74 PLAU (0.46) ALDH1A1KDM4EMAPTSMN1; SMN2GAA
SCHEMBL30986044 0.74 PKM (0.60) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL20615643 0.74 KDM4E (0.50) ALDH1A1KDM4EKMT2AGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026803-A1 PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS NOVARTIS AG (CH) 2021-02-18 WO disclosed